% | $
Quotes you view appear here for quick access.

Tekmira Pharmaceuticals Corporation Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • rnai_inv rnai_inv Feb 22, 2012 11:52 AM Flag

    Alny Lawsuit Revisited in light of current events

    I'm not sure if we are talking about the same, but MC3 is a type of lipid, which ALNY claims.
    The TKMR patent is a ratio and formulation of lipids, which can be with MC3, or another.
    If ALNY uses MC3 with a certain ratio/formulation, it needs both patents. If ALNY has a license to the ratio/formulation patent it can claim a proprietary delivery system, just like they didn't invent RNAi, but got the exclusive license.

    The billions in damages is always based on winning every claim and a multiple, almost never happens.

3.36-0.18(-5.08%)Jun 24 4:00 PMEDT